The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM).
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Serum and Salivary Resistin Levels (pg/ml)
Timeframe: Change between baseline, 1 and 3 months after non-surgical periodontal treatment
Serum and Salivary Leptin Levels (pg/ml)
Timeframe: Change baseline, 1 and 3 months after non-surgical periodontal treatment
Serum and Salivary Visfatin Levels (pg/ml)
Timeframe: Change baseline, 1 and 3 months after non-surgical periodontal treatment
Serum and saliva IL-1β levels (pg/ml)
Timeframe: Change baseline, 1 and 3 months after non-surgical periodontal treatment